Application
TTC13 Antibody (N-term) western blot analysis in U251 cell line lysates (35ug/lane).This demonstrates the TTC13 antibody detected the TTC13 protein (arrow).Application
TTC13 Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human cerebellum tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of TTC13 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | TTC13 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | TTC13; Tetratricopeptide repeat protein 13 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | TTC13 Tetratricopeptide repeat protein 13 |
|---|---|
| Molecular Weight(MW) | 96813 Da |
| Tissue Specificity | This TTC13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 194-224 amino acids from the N-terminal region of human TTC13. |
| Entrez Gene | 79573 |
|---|---|
| Nucleotide Accession | NP_078801.3 NP_001116307.2 |
Application
TTC13 Antibody (N-term) western blot analysis in U251 cell line lysates (35ug/lane).This demonstrates the TTC13 antibody detected the TTC13 protein (arrow).
Application
TTC13 Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human cerebellum tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of TTC13 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
